Ws Management Lllp Bluebird Bio, Inc. Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $9,472 - $19,351	-571 Reduced 4.85%	11,212 $338,000
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $55,026 - $93,273	-2,029 Reduced 14.69%	11,783 $719,000
Q1 2020 May 13, 2020	SELL	$26.16 - $63.5 $18,181 - $44,132	-695 Reduced 4.79%	13,812 $635,000
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $95,270 - $149,146	-1,602 Reduced 9.94%	14,507 $1.33 Million
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $144,551 - $200,530	-1,906 Reduced 10.58%	16,109 $2.05 Million
Q1 2019 May 13, 2019	SELL	$64.44 - $104.11 $156,395 - $252,674	-2,427 Reduced 11.87%	18,015 $2.83 Million
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $780,238 - $1.23 Million	-13,202 Reduced 39.24%	20,442 $2.03 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $3.35 Million - $4.29 Million	33,644 New	33,644 $5.28 Million

142

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.